

Mereo BioPharma Could Net USD300 Million From Navicixizumab Deal


Woodford Transfers Series Of Holdings To New Manager Schroders


Mereo Gets Positive Setrusumab Trial Results; Plans Pediatric Studies


PRESS: Consortium Circles Healthcare Assets Of Fund Manager Woodford


DIRECTOR DEALINGS: Mereo BioPharma Chair Buys GBP15,000 In Shares


Mereo BioPharma Drug Navicixizumab Gets Fast Track Designation In US


(Alliance News) - Mereo BioPharma Group PLC on Tuesday posted a slightly narrowed loss for the first half of 2019 on a gain from its OncoMed Pharmaceu...


(Alliance News) - Mereo BioPharma Group PLC on Friday said General Counsel Charles Sermon, Chief Executive Officer Denise Scots-Knight and Head of Cor...